Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07277257 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Interventions: Acoltremon ophthalmic solution 0.003% (Drug) to TRYPTYR (Acoltremon ophthalmic solution 0.003%) (Drug)v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will evaluate the effect of TRYPTYR in patients with Sjögren's syndrome-related dry eye disease. The goal is to determine whether TRYPTYR can improve symptoms and signs of dry eye in this specific patient population.
Trial Details
NCT Number NCT07277257
Lead Sponsor Center For Sight
Conditions
(from sponsor)		 Sjogren Syndrome With Keratoconjunctivitis
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov